1. Home
  2. CSIQ vs SLDB Comparison

CSIQ vs SLDB Comparison

Compare CSIQ & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Canadian Solar Inc. (ON)

CSIQ

Canadian Solar Inc. (ON)

HOLD

Current Price

$12.80

Market Cap

906.4M

Sector

Technology

ML Signal

HOLD

Logo Solid Biosciences Inc.

SLDB

Solid Biosciences Inc.

HOLD

Current Price

$8.70

Market Cap

932.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSIQ
SLDB
Founded
2001
2013
Country
Canada
United States
Employees
N/A
121
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
906.4M
932.9M
IPO Year
2006
2017

Fundamental Metrics

Financial Performance
Metric
CSIQ
SLDB
Price
$12.80
$8.70
Analyst Decision
Hold
Strong Buy
Analyst Count
10
11
Target Price
$17.36
$16.36
AVG Volume (30 Days)
1.8M
751.6K
Earning Date
05-14-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
34.97
EPS
N/A
N/A
Revenue
N/A
$8,094,000.00
Revenue This Year
$23.61
N/A
Revenue Next Year
$13.90
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.74
$3.79
52 Week High
$34.59
$11.45

Technical Indicators

Market Signals
Indicator
CSIQ
SLDB
Relative Strength Index (RSI) 40.18 45.19
Support Level $12.35 $6.25
Resistance Level $16.48 $11.45
Average True Range (ATR) 0.77 0.42
MACD -0.04 -0.06
Stochastic Oscillator 26.16 14.18

Price Performance

Historical Comparison
CSIQ
SLDB

About CSIQ Canadian Solar Inc. (ON)

Canadian Solar Inc is a Canadian solar technology and renewable energy company. It is a manufacturer of solar photovoltaic modules, a provider of battery energy storage solutions, and a developer of utility-scale solar power and battery energy storage projects. The company is organized in two segments: Manufacturing segment, comprising CS PowerTech, which focuses on manufacturing and sales of solar products, battery energy storage products, and other power technology products for the U.S. market and CSI Solar, which serves all other world-wide markets; and Recurrent Energy segment, which focuses on solar power and battery storage project development, asset sales, power services, and electricity revenue from its operating portfolio. It derives maximum revenue from Manufacturing segment.

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases. The majority of its current programs are designed to treat these diseases with gene transfer products. The company operates in a single segment, developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases.

Share on Social Networks: